This brand-new advocacy group is an unapologetic defender of high drug prices
(By Nicholas Florko for STAT) WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group
Read More(By Nicholas Florko for STAT) WASHINGTON — It’s less than a week old, but a shadowy new pharma advocacy group
Read More(By Kelly Gooch for Becker’s Hospital Review) The CEOs of more than 700 hospitals and health systems penned a letter to U.S.
Read More(By Rachel D. Cohen for NPR) When they’re sick, it seems Americans know what they want: antibiotics. And if they
Read More(By Martha Bebinger, WBUR in partnership that includes WBUR, NPR and Kaiser Health News.) It took more than 10 minutes for paramedics to
Read More(By Sarah Jane Tribble for Kaiser Health News) David Herzberg was alarmed when he heard that Richard Sackler, former chairman
Read MoreFar too many senior fail to address one of the most important expenses they are likely to incur: healthcare expenses.
Read More(By Alia Paavola for Becker’s Hospital Review) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C drugs,
Read More(By Harrison Cook for Becker’s Hospital Review) Congress revealed a 660-page revised opioids bill the night of Sept. 25 as part of
Read More(By Ed Silverman for STAT) As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers
Read MoreMedicare beneficiaries can change their Medicare Advantage or Medicare Prescription drug (Part D) coverage during the Medicare Annual Election Period
Read More